Remarkable elevation of fibrinolysis markers and procalcitonin associated with dabrafenib plus trametinib combination therapy: Uncommon adverse events

Corresponding Author

• ynakamura-tuk@umin.ac.jp

• orcid.org/0000-0003-0166-2658

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Correspondence: Yoshiyuki Nakamura, M.D., Ph.D., Department of Dermatology, Faculty of Medicine, University of Tsukuba, 1‐1‐1 Tennodai, Tsukuba, Ibaraki 305‐8575, Japan. Email: ynakamura-tuk@umin.ac.jp

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

• orcid.org/0000-0002-5398-0773

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

• orcid.org/0000-0001-7100-5800

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

• orcid.org/0000-0001-8254-9176

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

• orcid.org/0000-0003-3010-8496

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan